These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Low-dose cortisol for symptoms of posttraumatic stress disorder. Aerni A; Traber R; Hock C; Roozendaal B; Schelling G; Papassotiropoulos A; Nitsch RM; Schnyder U; de Quervain DJ Am J Psychiatry; 2004 Aug; 161(8):1488-90. PubMed ID: 15285979 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder--a pilot study. Isserles M; Shalev AY; Roth Y; Peri T; Kutz I; Zlotnick E; Zangen A Brain Stimul; 2013 May; 6(3):377-83. PubMed ID: 22921765 [TBL] [Abstract][Full Text] [Related]
24. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants. Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888 [TBL] [Abstract][Full Text] [Related]
25. An open-label study of mirtazapine as treatment for combat-related PTSD. Alderman CP; Condon JT; Gilbert AL Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388 [TBL] [Abstract][Full Text] [Related]
26. Quetiapine treatment in an open trial in combat-related post-traumatic stress disorder with psychotic features. Kozaric-Kovacic D; Pivac N Int J Neuropsychopharmacol; 2007 Apr; 10(2):253-61. PubMed ID: 16945162 [TBL] [Abstract][Full Text] [Related]
36. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. Pollack MH; Hoge EA; Worthington JJ; Moshier SJ; Wechsler RS; Brandes M; Simon NM J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352 [TBL] [Abstract][Full Text] [Related]
37. Effectiveness of sildenafil in treating erectile dysfunction in PTSD patients: a double-blind, placebo-controlled crossover study. Orr G; Weiser M; Polliack M; Raviv G; Tadmor D; Grunhaus L J Clin Psychopharmacol; 2006 Aug; 26(4):426-30. PubMed ID: 16855464 [TBL] [Abstract][Full Text] [Related]
38. Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. Lane HY; Lin CH; Green MF; Hellemann G; Huang CC; Chen PW; Tun R; Chang YC; Tsai GE JAMA Psychiatry; 2013 Dec; 70(12):1267-75. PubMed ID: 24089054 [TBL] [Abstract][Full Text] [Related]
39. Open trial of citalopram in adults with post-traumatic stress disorder. Seedat S; Stein DJ; Emsley RA Int J Neuropsychopharmacol; 2000 Jun; 3(2):135-140. PubMed ID: 11343590 [TBL] [Abstract][Full Text] [Related]
40. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder. Berlant JL BMC Psychiatry; 2004 Aug; 4():24. PubMed ID: 15315714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]